About
Technology
Issues
FAQ
Search
Rankings
Journals
Disciplines
Institutions
Schools/Departments
Field Rankings
Scientometrics
★★(★)
Articles
h
-index
g
-index
Journals
Co-Authors
Publications (by citations)
Publications (by year)
Citation Distribution
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Authors
›
Siqing Fu
›
journal-rankings
Siqing Fu
171
(top 1%)
papers
7.6K
(top 2%)
citations
45
(top 2%)
h
-index
81
(top 2%)
g
-index
177
all documents
7.9K
doc citations
1.5K
citing journals
105
times ranked
Filter by:
Articles (Lifetime) (4)
|
Articles (per year) (1)
|
Citations (Lifetime) (2)
|
Citations (per year) (9)
|
Most Cited Article (Lifetime) (1)
|
Most Cited Article (per year) (16)
|
Low Rankings (Lifetime) (13)
|
Low Rankings (per year) (111)
|
1
st
most cited author
in
Investigational New Drugs
(2018) [with 256 citations of 3 articles]
2
nd
most published author
in
Oncotarget
(2014) [with 7 articles having 219 citations]
2
nd
most cited paper
in
Investigational New Drugs
(2018) [with 256 citations of an article]
5
th
most published author
in
Investigational New Drugs
(lifetime) [with 16 articles having 512 citations]
7
th
most cited paper
in
Molecular Cancer Therapeutics
(2011) [with 333 citations of an article]
9
th
most cited author
in
Molecular Cancer Therapeutics
(2011) [with 333 citations of 2 articles]
9
th
most cited author
in
Investigational New Drugs
(lifetime) [with 512 citations of 16 articles]
11
th
most cited paper
in
Oncoscience
(2013) [with 25 citations of an article]
17
th
most published author
in
Oncotarget
(lifetime) [with 24 articles having 793 citations]
17
th
most cited author
in
Investigational New Drugs
(2015) [with 115 citations of 5 articles]
18
th
most cited author
in
Clinical Cancer Research
(2012) [with 797 citations of 4 articles]
25
th
most cited author
in
Oncotarget
(2013) [with 200 citations of 5 articles]
27
th
most published author
in
Molecular Cancer Therapeutics
(lifetime) [with 10 articles having 760 citations]
35
th
most cited paper
in
Expert Opinion on Therapeutic Targets
(2006) [with 23 citations of an article]
38
th
most cited paper
in
Investigational New Drugs
(2015) [with 115 citations of an article]
41
st
most cited paper
in
International Journal of Gynecological Cancer
(2006) [with 26 citations of an article]
41
st
most cited paper
in
Expert Opinion on Investigational Drugs
(2018) [with 43 citations of an article]
42
nd
most cited paper
in
Clinical Cancer Research
(2012) [with 797 citations of an article]
45
th
most cited paper
in
Investigational New Drugs
(2013) [with 51 citations of an article]
47
th
most published author
in
Cancer Chemotherapy and Pharmacology
(lifetime) [with 11 articles having 225 citations]
47
th
most cited author
in
Molecular Cancer Therapeutics
(lifetime) [with 760 citations of 10 articles]
51
st
most cited paper
in
Cancer Chemotherapy and Pharmacology
(2014) [with 46 citations of an article]
51
st
most cited author
in
Molecular Cancer Therapeutics
(2016) [with 151 citations of 2 articles]
55
th
most cited paper
in
Cancer Chemotherapy and Pharmacology
(2018) [with 51 citations of an article]
58
th
most cited paper
in
Investigational New Drugs
(lifetime) [with 512 citations of an article]
65
th
most cited paper
in
Clinical Breast Cancer
(2014) [with 29 citations of an article]
66
th
most cited author
in
Molecular Cancer Therapeutics
(2012) [with 137 citations of 2 articles]
77
th
most cited paper
in
Investigational New Drugs
(2017) [with 32 citations of an article]
84
th
most cited paper
in
Investigational New Drugs
(2014) [with 56 citations of an article]
87
th
most cited paper
in
JCO Precision Oncology
(2017) [with 107 citations of an article]
89
th
most cited author
in
JCO Precision Oncology
(2017) [with 107 citations of 1 articles]
90
th
most cited paper
in
Expert Opinion on Therapeutic Targets
(2015) [with 36 citations of an article]
98
th
most cited author
in
Cancer
(2011) [with 209 citations of 2 articles]
site/software ©
exaly
; All materials licenced under
CC by-SA
.